PURIFICATION AND RECONSTITUTION OF ACTIVE GAMMA SECRETASE COMPLEX
PURIFICATION AND RECONSTITUTION OF ACTIVE GAMMA SECRETASE COMPLEX
批准号:
7483170
负责人:
DENNIS J SELKOE
金额:
$42.79万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2008-08-31
关键词:
Active SitesAddressAffinityAlzheimer&aposs DiseaseAmyloid beta-ProteinAmyloid beta-Protein PrecursorAspartateAspartic EndopeptidasesBindingBiochemicalBiochemical GeneticsBiological AssayBiologyC83Caenorhabditis elegansCalciumCellsChemicalsClassCleaved cellComplexCytoplasmic ProteinDetergentsDevelopmentDiseaseDockingEndopeptidasesEnvironmentEnzymesGeneticGoalsGuanosine TriphosphateHealthIn VitroIntegral Membrane ProteinIonsKineticsKnowledgeLaboratoriesLightMTCH1 geneMammalian CellMass Spectrum AnalysisMediator of activation proteinMembrane ProteinsMetabolicPVRL1Peptide HydrolasesPhospholipidsPropertyProteinsProteolysisProtocols documentationRangeRateResearchSignal PathwayTherapeuticTimeTransmembrane DomainVesicleWorkYeastsbasebeta-site APP cleaving enzyme 1calsenilincofactordesigndimergamma secretasehuman APH-1 proteinhuman PEN-2 proteininhibitor/antagonistinterestmembernicastrin proteinnotch proteinnovelpresenilinreconstitutionscale upsecretasesizestoichiometry
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Gamma-Secretase is an unusual enzyme that catalyzes the intramembrane proteolysis of numerous type I integral membrane proteins. These include the amyloid-beta protein precursor (APP), which releases the amyloid-beta peptide (Abeta) implicated in Alzheimer's disease (AD). For this reason, gamma-secretase is a prime target for the development of therapeutic and preventative agents for AD. Pharmacological, genetic, and biochemical evidence generated under this project strongly supports the hypothesis that the polytopic membrane protein, presenilin (PS), is the catalytic component of a larger multi-protein gamma-secretase complex. PS is normally cleaved into two fragments that remain associated. These heterodimers are metabolically stable, and their formation is tightly regulated by limiting cellular factors. During the current project period, we discovered that both PS endoproteolysis and gamma-secretase
activity require two conserved transmembrane aspartates, consistent with our provocative hypothesis that presenilin undergoes autoproteolysis to become the catalytic component of a novel aspartyl protease. Moreover, using affinity isolation on a designed inhibitor, we showed that the PS-associated protein, nicastrin, is another member of the complex. Recently, our laboratory has found that the co-expression of PS1, nicastrin, and two proteins identified in C. elegans, aph-1 and pen-2, results in increased PS heterodimer formation, full nicastrin
maturation and enhanced gamma-secretase activity. All 4 proteins co-immunoprecipitate and bind to a gamma-secretase affinity matrix. Taken together, these new finding suggest that PS, nicastrin, aph-1, and pen-2 assemble as a complex that leads to the formation of active gamma-secretase. In light of these discoveries, we now propose to purify, fully characterize and then reconstitute active gamma-secretase. Specifically, we will: 1) scale up and refine the multi-step purification protocols for gamma-secretase established by our labs in order to unequivocally confirm the presence of these 4 key components and search for any additional protein factors by mass spectrometry; 2) systematically explore phospholipid, detergent, ionic, energy, pH and other requirements to optimize our established in vitro cleavage assay (which can generate Abeta, AICD and NICD) and characterize the kinetic properties of the protease;
and 3) using this new knowledge, carry out the step-wise addition of recombinantly expressed PS, nicastrin, aph-1, and pen-2 in a pure detergent/phospholipid environment to reconstitute proteolysis. The purification, detailed characterization, and reconstitution of gamma-secretase will aid the understanding of this essential protease in health and disease and the search for effective and safe AD therapeutics. Moreover, this work will advance our fundamental knowledge of a unique new class of intramembrane-cleaving proteases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A new look at mechanism-based Alzheimer's Disease biomarkers in blood
-
批准号:9763401
-
项目类别:
-
资助金额:$22.38万
-
财政年份:2018
-
负责人:DENNIS J SELKOE
-
依托单位:
Pathological Changes of Alpha-Synuclein Structure in the Brain
-
批准号:9788107
-
项目类别:
-
资助金额:$22.38万
-
财政年份:2018
-
负责人:DENNIS J SELKOE
-
依托单位:
Biology of Native Alpha-Synuclein Tetramers in Parkinson's Disease
-
批准号:8631204
-
项目类别:
-
资助金额:$36.82万
-
财政年份:2014
-
负责人:DENNIS J SELKOE
-
依托单位:
Pathogenic Mechanisms of Cell-Derived Abeta Oligomers
-
批准号:8337011
-
项目类别:
-
资助金额:$13.57万
-
财政年份:2011
-
负责人:DENNIS J SELKOE
-
依托单位:
AMYLOID B-PROTEIN AND IMMUNE MARKERS IN HUMAN BLOOD
-
批准号:7719366
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2008
-
负责人:DENNIS J SELKOE
-
依托单位:
Administrative Core
-
批准号:7498199
-
项目类别:
-
资助金额:$9.03万
-
财政年份:2007
-
负责人:DENNIS J SELKOE
-
依托单位:
AMYLOID B-PROTEIN AND IMMUNE MARKERS IN HUMAN BLOOD
-
批准号:7607424
-
项目类别:
-
资助金额:$0.86万
-
财政年份:2007
-
负责人:DENNIS J SELKOE
-
依托单位:
Alpha-Synuclein, PUFA and Membrane Vesicles-Health/PD
-
批准号:7032775
-
项目类别:
-
资助金额:$31.21万
-
财政年份:2006
-
负责人:DENNIS J SELKOE
-
依托单位:
Pathogenic Mechanisms of Cell-Derived Abeta Oligomers
-
批准号:7027342
-
项目类别:
-
资助金额:$44.18万
-
财政年份:2006
-
负责人:DENNIS J SELKOE
-
依托单位:
Pathogenic Mechanisms of Cell-Derived Abeta Oligomers
-
批准号:7798985
-
项目类别:
-
资助金额:$52.95万
-
财政年份:2006
-
负责人:DENNIS J SELKOE
-
依托单位:
Pathogenic Mechanisms of Cell-Derived Abeta Oligomers
-
批准号:7216719
-
项目类别:
-
资助金额:$44.19万
-
财政年份:2006
-
负责人:DENNIS J SELKOE
-
依托单位:
Alpha-Synuclein, PUFA and Membrane Vesicles in Health and Parkinson's Disease
-
批准号:7345401
-
项目类别:
-
资助金额:$30.83万
-
财政年份:2006
-
负责人:DENNIS J SELKOE
-
依托单位:
Alpha-Synuclein, PUFA and Membrane Vesicles in Health and Parkinson's Disease
-
批准号:7552008
-
项目类别:
-
资助金额:$31.09万
-
财政年份:2006
-
负责人:DENNIS J SELKOE
-
依托单位:
Pathogenic Mechanisms of Cell-Derived Abeta Oligomers
-
批准号:7596374
-
项目类别:
-
资助金额:$51.92万
-
财政年份:2006
-
负责人:DENNIS J SELKOE
-
依托单位:
Pathogenic Mechanisms of Cell-Derived Abeta Oligomers
-
批准号:7369681
-
项目类别:
-
资助金额:$50.41万
-
财政年份:2006
-
负责人:DENNIS J SELKOE
-
依托单位:
Alpha-Synuclein, PUFA and Membrane Vesicles in Health and Parkinson's Disease
-
批准号:7167721
-
项目类别:
-
资助金额:$30.56万
-
财政年份:2006
-
负责人:DENNIS J SELKOE
-
依托单位:
Alpha-Synuclein, PUFA and Membrane Vesicles in Health and Parkinson's Disease
-
批准号:7751344
-
项目类别:
-
资助金额:$31.04万
-
财政年份:2006
-
负责人:DENNIS J SELKOE
-
依托单位:
AMYLOID PRECURSOR PROTEIN IN HUMAN BLOOD
-
批准号:7204477
-
项目类别:
-
资助金额:$0.58万
-
财政年份:2005
-
负责人:DENNIS J SELKOE
-
依托单位:
Amyloid Precursor Protein in Human Blood
-
批准号:7045551
-
项目类别:
-
资助金额:$0.66万
-
财政年份:2003
-
负责人:DENNIS J SELKOE
-
依托单位:
MECHANISM AND INHIBITION OF NATIVE AMYLOID BETA AGGREGATION IN CELLS
-
批准号:6314324
-
项目类别:
-
资助金额:$27.73万
-
财政年份:2000
-
负责人:DENNIS J SELKOE
-
依托单位:
海外基金